Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PerkinElmer Announces Strategic Alliance with Integromics

Published: Tuesday, June 25, 2013
Last Updated: Tuesday, June 25, 2013
Bookmark and Share
PerkinElmer becomes the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire.

OmicsOffice® 5 improves and accelerates genomic analysis workflows by enabling integrated comparison of data from microarray, next generation sequencing and qPCR experiments within the TIBCO Spotfire® analytics platform.

PerkinElmer, Inc. announced a strategic alliance with Integromics, S.L. to become the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire data visualization platform. In addition, PerkinElmer and Integromics announced the release of OmicsOffice 5.0, developed by Integromics. The new OmicsOffice software will be exclusively available from PerkinElmer under the agreement.

OmicsOffice allows users of TIBCO Spotfire to handle, process, analyze and properly visualize diverse genomics data. The software provides scientists with a rich and flexible set of statistical and functional analysis tools specifically for the study and cross-validation of microarray, next generation sequencing and qPCR data on a single platform, and allows them to extract relevant and reliable biological conclusions from genomic data. Using OmicsOffice, genomics scientists can significantly improve the quality of their results, as they respond to scalability and integration challenges in this rapidly evolving field.

Michael Stapleton, general manager, PerkinElmer Informatics said, “We are delighted that PerkinElmer will take on distribution of the new OmicsOffice product. It represents a true synergy with our mission to offer end-to-end informatics solutions throughout the research, discovery and manufacturing processes. As the exclusive worldwide distributor of OmicsOffice, we can provide focused solutions to the genomics and next generation sequencing community to improve the quality of their work and gain critical insights faster than before.”

“PerkinElmer is the perfect partner for Integromics, particularly for OmicsOffice,” said Víctor Canivell, PhD, Chief Executive Officer of Integromics. “PerkinElmer’s leadership in technologies for scientific discovery and its commitment to advanced analysis tools, provides us with an excellent opportunity to bring the power of OmicsOffice to genomic researchers, as well as to accelerate the release of new omics analysis tools.”

PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PerkinElmer Signals™ Perspectives Launches in Collaboration with Attivio
New data discovery solution leverages Attivio's platform to provide insight into complex scientific challenges.
Tuesday, February 02, 2016
PerkinElmer Revenues Grow 4%
PerkinElmer, Inc. reported financial results for the fourth quarter ended December 29, 2013.
Monday, February 03, 2014
CAS and PerkinElmer Combine the Power of SciFinder and ChemBioDraw
New functionality will enable ChemBioDraw users to search in SciFinder, providing access to comprehensive content available in the CAS databases.
Tuesday, December 17, 2013
PerkinElmer to Host Revolutionaries for Global Health Summit
Company to assemble thought leaders to share pioneering personalized health research and innovations.
Wednesday, May 01, 2013
PerkinElmer and MGH Pathology Collaborate
Collaboration to develop a complete sequencing informatics system for cancer research.
Wednesday, September 12, 2012
PerkinElmer Announces Acquisition of Geospiza
The acquisition of Geospiza supports PerkinElmer’s growing offerings in Next Generation DNA Sequencing and Analysis Services, enabling researchers to explore the genomic origins of disease more effectively.
Monday, May 16, 2011
PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation and Completes Purchase of ArtusLabs, Inc.
These acquisitions will enhance the Company’s focus on knowledge management in laboratory settings by expanding its informatics and software offerings.
Thursday, March 24, 2011
Scientific News
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Personalised Medicine: Dose by Design
Personalised medicine holds the promise of a new approach to healthcare, tailored exactly to our individual needs, as Congenica's Nick Lench discussed on a recent BBC Radio 4 programme.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
Computers Better Predict Lung Cancer Type, Severity
Study shows automating the analysis of cancer tissue samples increases the accuracy of tumor classification and patient prognoses.
Using Big Data to Discover Potential Cancer Biomarkers
University of Hawai'i Cancer Center researchers used "Big Data" to discover potential cancer biomarkers, a panel of six long intergenic non-coding RNAs (lincRNAs), for the diagnosis of all types of cancers including lung, breast, prostate, liver and ovarian cancers.
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Algorithm To Find Precise Cancer Treatments For Patients Developed
The JAMMIT algorithm could help predict which patients will benefit most from chemotherapy.
Depression Genetics Insight from Crowd-Sourced Data
Genome sites liked to depression have been discovered from data shared by people who had purchased their genetic profiles online.
Detecting Hazardous Chemicals in Complex Mixtures
Researchers are pioneering a new chemical substance analyis software technique that could increase illicit substance detection.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!